Skip to content

Anika Therapeutics, Inc.: 10-K filed 2015-03-13

What Anika Therapeutics, Inc. reported in its annual report filed 2015-03-13 (fiscal FY 2014): 39 published measures, 141 facts as tagged in accession 0001171843-15-001395.

This filing

Form
10-K (annual report)
Filed
2015-03-13
Fiscal period
fiscal FY 2014
Accession
0001171843-15-001395 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Anika Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-31193,996,376USD
At 2013-12-31156,041,881USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-31178,097,097USD
At 2013-12-31135,634,031USD
At 2012-12-31108,925,134USD
At 2011-12-3194,762,778USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-31100,155,864USD
At 2013-12-3163,333,160USD
At 2012-12-3144,067,477USD
At 2011-12-3135,777,222USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-317,816,076USD92
2014-01-01 to 2014-12-3138,319,479USD365
2014-07-01 to 2014-09-306,170,800USD92
2014-04-01 to 2014-06-309,302,350USD91
2014-01-01 to 2014-03-3115,030,253USD90
2013-10-01 to 2013-12-316,654,369USD92
2013-01-01 to 2013-12-3120,574,521USD365
2013-07-01 to 2013-09-304,957,258USD92
2013-04-01 to 2013-06-305,894,892USD91
2013-01-01 to 2013-03-313,068,002USD90
2012-01-01 to 2012-12-3111,757,460USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,552,922USD365
2013-01-01 to 2013-12-31440,890USD365
2012-01-01 to 2012-12-311,504,707USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31104,903,681USD
At 2013-12-3166,584,202USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-01-01 to 2014-12-3114,678,240shares365
2013-01-01 to 2013-12-3114,086,912shares365
2012-01-01 to 2012-12-3113,260,739shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-10-01 to 2014-12-3115,277,583shares92
2014-01-01 to 2014-12-3115,269,435shares365
2014-07-01 to 2014-09-3015,434,875shares92
2014-04-01 to 2014-06-3015,492,732shares91
2014-01-01 to 2014-03-3115,499,447shares90
2013-10-01 to 2013-12-3115,084,738shares92
2013-01-01 to 2013-12-3114,825,599shares365
2013-07-01 to 2013-09-3014,958,965shares92
2013-04-01 to 2013-06-3014,578,927shares91
2013-01-01 to 2013-03-3114,357,110shares90
2012-01-01 to 2012-12-3114,344,577shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-10-01 to 2014-12-310.53USD/shares92
2014-01-01 to 2014-12-312.61USD/shares365
2014-07-01 to 2014-09-300.42USD/shares92
2014-04-01 to 2014-06-300.63USD/shares91
2014-01-01 to 2014-03-311.04USD/shares90
2013-10-01 to 2013-12-310.47USD/shares92
2013-01-01 to 2013-12-311.46USD/shares365
2013-07-01 to 2013-09-300.36USD/shares92
2013-04-01 to 2013-06-300.44USD/shares91
2013-01-01 to 2013-03-310.23USD/shares90
2012-01-01 to 2012-12-310.89USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-10-01 to 2014-12-310.51USD/shares92
2014-01-01 to 2014-12-312.51USD/shares365
2014-07-01 to 2014-09-300.4USD/shares92
2014-04-01 to 2014-06-300.6USD/shares91
2014-01-01 to 2014-03-310.97USD/shares90
2013-10-01 to 2013-12-310.44USD/shares92
2013-01-01 to 2013-12-311.39USD/shares365
2013-07-01 to 2013-09-300.33USD/shares92
2013-04-01 to 2013-06-300.4USD/shares91
2013-01-01 to 2013-03-310.21USD/shares90
2012-01-01 to 2012-12-310.82USD/shares366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-12-3123,185,542USD365
2013-01-01 to 2013-12-3111,905,010USD365
2012-01-01 to 2012-12-317,769,961USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-3131,668,883USD
At 2013-12-3132,938,711USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,607,421USD365
2013-01-01 to 2013-12-311,268,070USD365
2012-01-01 to 2012-12-311,151,199USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-3161,446,884USD365
2013-01-01 to 2013-12-3132,606,717USD365
2012-01-01 to 2012-12-3119,715,198USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-31139,025,042USD
At 2013-12-3194,591,787USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-315,973,262USD
At 2013-12-319,282,501USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-12-311,201,226USD
At 2013-12-312,793,911USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2014-12-318,338,699USD
At 2013-12-319,443,894USD
At 2012-12-319,065,891USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-12-3117,152,028USD
At 2013-12-3118,736,845USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-12-3112,406,776USD
At 2013-12-3110,996,785USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-10-01 to 2014-12-3112,368,539USD92
2014-07-01 to 2014-09-3016,250,512USD92
2014-04-01 to 2014-06-3015,934,243USD91
2014-01-01 to 2014-03-319,990,386USD90
2013-10-01 to 2013-12-3113,953,154USD92
2013-07-01 to 2013-09-3011,645,778USD92
2013-04-01 to 2013-06-3013,756,075USD91
2013-01-01 to 2013-03-319,653,319USD90

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-01-01 to 2014-12-3115,073,485USD365
2013-01-01 to 2013-12-3112,936,001USD365
2012-01-01 to 2012-12-3114,728,662USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-318,144,152USD365
2013-01-01 to 2013-12-317,059,875USD365
2012-01-01 to 2012-12-315,388,036USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3114,851,703shares
At 2013-12-3114,289,308shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-3153,619,589USD
At 2013-12-3152,413,423USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-3121,950,706USD
At 2013-12-3119,474,712USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-12-3114,894,710USD
At 2013-12-3118,998,409USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-31893,935USD
At 2013-12-311,133,544USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-314,747,526USD
At 2013-12-315,537,881USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-12-31959,305USD
At 2013-12-31865,957USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-3161,505,021USD365
2013-01-01 to 2013-12-3132,479,531USD365
2012-01-01 to 2012-12-3119,527,421USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-3135,523,774USD365
2013-01-01 to 2013-12-3121,530,056USD365
2012-01-01 to 2012-12-3112,170,011USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-12-312,612,799USD365
2013-01-01 to 2013-12-312,678,745USD365
2012-01-01 to 2012-12-312,496,749USD366

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-01-01 to 2014-12-312,092,803USD365
2013-01-01 to 2013-12-312,093,746USD365
2012-01-01 to 2012-12-312,028,498USD366

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2014-01-01 to 2014-12-3122,388,179USD365
2013-01-01 to 2013-12-319,699,402USD365
2012-01-01 to 2012-12-318,291,595USD366

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2014-01-01 to 2014-12-31815,169USD365
2013-01-01 to 2013-12-312,205,608USD365
2012-01-01 to 2012-12-31-10,269USD366

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-897,561USD365
2013-01-01 to 2013-12-31-2,411,247USD365
2012-01-01 to 2012-12-314,271,129USD366

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-311,974,423USD365
2013-01-01 to 2013-12-312,823,059USD365
2012-01-01 to 2012-12-312,370,318USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-749,601USD365
2013-01-01 to 2013-12-31622,928USD365
2012-01-01 to 2012-12-31-2,879,330USD366

Inspect the source

Entity
Anika Therapeutics, Inc. / CIK 0000898437
Captured
2026-09-20T05:04:56.960Z
SEC response SHA-256
f1da3290842851cfa646165073c3c5bf9c06212e35bc3d1892f2be77cae8b535

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000898437.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))